Essex Investment Management CO LLC Supernus Pharmaceuticals, Inc. Transaction History

Essex Investment Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$30.84 - $49.51 $1.97 Million - $3.16 Million	-63,754 Closed	0 $0
Q3 2018 Oct 16, 2018	BUY	$42.7 - $56.55 $87,193 - $115,475	2,042 Added 3.31%	63,754 $3.21 Million
Q2 2018 Jul 17, 2018	BUY	$44.1 - $59.85 $2,601 - $3,531	59 Added 0.1%	61,712 $3.69 Million
Q1 2018 Apr 26, 2018	SELL	$37.15 - $46.9 $130,322 - $164,525	-3,508 Reduced 5.38%	61,653 $2.82 Million
Q4 2017 Feb 05, 2018	BUY	$36.4 - $42.6 $69,778 - $81,664	1,917 Added 3.03%	65,161 $2.6 Million
Q3 2017 Oct 30, 2017	BUY	$36.75 - $49.65 $2.32 Million - $3.14 Million	63,244	63,244 $2.53 Million

281

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.95B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Essex Investment Management CO LLC with notifications on news.